ERBB2 and breast carcinoma: The regulation of cell proliferation in HER2-positive breast cancer cell line with CHD4 depletion is explained by the observed increase in HER2 Tyr-1248 phosphorylation and subsequent inhibition of the downstream HER2/PI3K/AKT/ERK signaling cascade.